147 related articles for article (PubMed ID: 8380945)
1. Red cell alterations associated with virucidal methylene blue phototreatment.
Wagner SJ; Storry JR; Mallory DA; Stromberg RR; Benade LE; Friedman LI
Transfusion; 1993 Jan; 33(1):30-6. PubMed ID: 8380945
[TBL] [Abstract][Full Text] [Related]
2. Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue.
Wagner SJ; Skripchenko A; Robinette D; Mallory DA; Cincotta L
Transfusion; 1998 Aug; 38(8):729-37. PubMed ID: 9709780
[TBL] [Abstract][Full Text] [Related]
3. Use of a flow-cell system to investigate virucidal dimethylmethylene blue phototreatment in two RBC additive solutions.
Wagner S; Skripchenko A; Thompson-Montgomery D
Transfusion; 2002 Sep; 42(9):1200-5. PubMed ID: 12430679
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions.
Skripchenko A; Robinette D; Wagner SJ
Photochem Photobiol; 1997 Mar; 65(3):451-5. PubMed ID: 9077130
[TBL] [Abstract][Full Text] [Related]
5. Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells.
Wagner SJ; Skripchenko A; Thompson-Montgomery D
Photochem Photobiol; 2002 Nov; 76(5):514-7. PubMed ID: 12462646
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization.
Wagner SJ; Robinette D; Storry J; Chen XY; Shumaker J; Benade L
Transfusion; 1994 Jun; 34(6):521-6. PubMed ID: 8023394
[TBL] [Abstract][Full Text] [Related]
7. Virus photoinactivation in stroma-free hemoglobin with methylene blue or 1,9-dimethylmethylene blue.
Hirayama J; Wagner SJ; Gomez C; Macdonald VW; Abe H; Ikeda H; Ikebuchi K; Sekiguchi S
Photochem Photobiol; 2000 Jan; 71(1):90-3. PubMed ID: 10649894
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of different antiviral treatments on the antioxidant systems of stroma-free hemoglobin.
Hirayama J; Abe H; Kamo N; Ikebuchi K; Ikeda H
Photochem Photobiol; 2001 Sep; 74(3):461-4. PubMed ID: 11594061
[TBL] [Abstract][Full Text] [Related]
9. Analysis of viral DNA, protein and envelope damage after methylene blue, phthalocyanine derivative or merocyanine 540 photosensitization.
Abe H; Wagner SJ
Photochem Photobiol; 1995 Apr; 61(4):402-9. PubMed ID: 7740085
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion.
Hornsey VS; Casey C; McColl K; Young H; Drummond O; McMillan L; Morrison A; Prowse CV
Vox Sang; 2011 Jul; 101(1):28-34. PubMed ID: 21175669
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB.
Skripchenko AA; Wagner SJ
Transfusion; 2000 Aug; 40(8):968-75. PubMed ID: 10960525
[TBL] [Abstract][Full Text] [Related]
12. Thiazole orange, a DNA-binding photosensitizer with flexible structure, can inactivate pathogens in red blood cell suspensions while maintaining red cell storage properties.
Skripchenko A; Wagner SJ; Thompson-Montgomery D; Awatefe H
Transfusion; 2006 Feb; 46(2):213-9. PubMed ID: 16441597
[TBL] [Abstract][Full Text] [Related]
13. Use of a flexible thiopyrylium photosensitizer and competitive inhibitor for pathogen reduction of viruses and bacteria with retention of red cell storage properties.
Wagner SJ; Skripchenko A; Cincotta L; Thompson-Montgomery D; Awatefe H
Transfusion; 2005 May; 45(5):752-60. PubMed ID: 15847665
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting virus photoinactivation by a series of phenothiazine dyes.
Wagner SJ; Skripchenko A; Robinette D; Foley JW; Cincotta L
Photochem Photobiol; 1998 Mar; 67(3):343-9. PubMed ID: 9523534
[TBL] [Abstract][Full Text] [Related]
15. In vivo recovery and survival of red cells after photodynamic treatment with thiopyrylium and red light using a canine model.
Skripchenko A; Balch A; Mackin A; Wagner SJ
Vox Sang; 2007 Feb; 92(2):157-9. PubMed ID: 17298580
[TBL] [Abstract][Full Text] [Related]
16. The 24-hour posttransfusion survival, oxygen transport function, and residual hemolysis of human outdated-rejuvenated red cell concentrates after washing and storage at 4 degrees C for 24 to 72 hours.
Valeri CR; Gray AD; Cassidy GP; Riordan W; Pivacek LE
Transfusion; 1984; 24(4):323-6. PubMed ID: 6464156
[TBL] [Abstract][Full Text] [Related]
17. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
Beutler E; West C
J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
[TBL] [Abstract][Full Text] [Related]
18. The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected.
Besselink GA; Van Engelenburg FA; Korsten HG; Blokker DE; Lagerberg JW; Brand A; De Korte D; Verhoeven AJ
Transfusion; 2002 Jun; 42(6):728-33. PubMed ID: 12147025
[TBL] [Abstract][Full Text] [Related]
19. Storage of saline-adenine-glucose-mannitol-suspended red cells in a new plastic container: polyvinylchloride plasticized with butyryl-n-trihexyl-citrate.
Högman CF; Eriksson L; Ericson A; Reppucci AJ
Transfusion; 1991 Jan; 31(1):26-9. PubMed ID: 1898784
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylene blue-treated plasma on red cells and stored platelet concentrates.
Perrotta PL; Baril L; Tead C; Chapman J; Dincecco D; Buchholz DH; Snyder EL
Transfusion; 1999 Jan; 39(1):63-9. PubMed ID: 9920168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
